Pharmaceutical giant AstraZeneca announced the launch of Evinova, a health technology business focused on bringing digital health solutions already in use globally by the pharma company to clinical research organizations (CROs), trial sponsors and care teams, and patients.
The new company will use established digital technology solutions to streamline clinical trial design and delivery in order...
Clinical trial startup Inato scooped up $20 million in a Series A2 funding round led by Cathay Innovation.
The raise included returning investor Obvious Ventures and new participants La Maison and Top Harvest Capital. The company previously raised $14 million in Series A funding in 2020.
WHAT IT DOES
Inato offers a technology platform that connects pharma companies and potential clinical trial...
The Digital Medicine Society (DiMe) and a suite of digital health and pharma players partnered to launch a toolkit aimed at improving diversity, equity and inclusion in clinical trials.
The resources include a guide to each step of a digital clinical trial, shared definitions of terms like "diversity" and "equity," a list of different digital tools that could be used and the potential benefits...
Clinical trial tech company Science 37 announced Thursday it has acquired a life science platform from Vault Health, which offers COVID-19 testing and health-screening services for employers.
Science 37 said the deal accelerates its plans to add features like advanced scheduling, investigational product tracking and data sharing with electronic data capture systems and EHRs.
The company said...
Tech-enabled clinical trial platform Paradigm announced its launch alongside a $203 million Series A funding round co-led by ARCH Venture Partners and General Catalyst.
F-Prime Capital, LUX Capital, GV, Magnetic Ventures and Mubadala Capital also participated in the round. American Cancer Society's BrightEdge fund was a strategic investor.
The company also announced its acquisition of Deep Lens...
Digital health tech company Huma acquired clinical trial data specialist Alcedis, expanding the British company's capabilities in the digital clinical trial space.
Huma will create an advanced clinical trials division utilizing German-based Alcedis' platform that will offer digital health solutions spanning various stages of the development process, from early stage development to phase 4...
ASX-listed health tech firm CardieX announced its subsidiary, medical technology company ATCOR, will partner with AI-enabled health tech company Invaryant to conduct joint clinical research on maternal health and cardiovascular disease.
Invaryant's health platform will integrate digital vascular biomarkers gathered from ATCOR's SphygmoCor arterial technology, which measures the central aortic...
Lokavant, which provides a data analytics platform for clinical trials, raised $21 million in a funding round led by Edison Partners.
Roivant Sciences, which builds health tech and biotech companies called "Vants," participated in the raise. Lokavant was incubated at Roivant and piloted its platform with some of the company's other biotech ventures.
As part of the fundraise, Gregg Michaelson,...
Decentralized clinical trial company Curebase is partnering with Meru Health on a three-year clinical trial to study the effectiveness of Meru's 12-week treatment program aimed at reducing depression among primary care patients.
Meru Health's smartphone-based, therapist-guided treatment program targets depression, burnout and anxiety, while Curebase provides a decentralized clinical trial...
Patient data capture and clinical trial tech company uMotif announced Wednesday it had secured $25.5 million from a fund managed by Athyrium Capital Management.
The London-based firm raised £5 million in a Series A funding in 2020 and £2.4 million in 2018.
WHAT IT DOEs
uMotif makes software for gathering patient data for clinical trials and research, including decentralized studies. Its offerings...